StockData
Revolution Medicines, Inc. logo

Revolution Medicines, Inc. (RVMD) bonds

RVMDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMDW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 3/30
$159.82−2.87 (-1.76%)

Close on Nov 18, 2026Market cap $34.26BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Revolution Medicines reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Revolution Medicines's 10-Q for the period ended Jun 30, 2026

IssueCouponMaturesAmount issuedCarrying value
0.50% Convertible Senior Notes Due 2033
Convertible at $199 a share
0.50%May 1, 2033$500.00M$517.50M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?